Amdoxovir
From Self-sufficiency
Revision as of 19:55, 23 July 2010 by Citation bot (Talk) (Citations: [177] added: doi, pmid. Edgar181)
| File:Amdoxovir structure.png | |
| Systematic (IUPAC) name | |
|---|---|
|
[(2R,4R)-4-(2,6-Diaminopurin-9-yl)-1,3-dioxolan-2-yl]methanol | |
| Identifiers | |
| CAS Number | 145514-04-1 |
| ATC code | none |
| PubChem | CID 124088 |
| Chemical data | |
| Formula | C9H12N6O3 |
| Molar mass | 252.23 g/mol[[Script error: No such module "String".]] |
Amdoxovir is an nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV. It was discovered by R.F. Schinazi (Emory University) and C.K. Chu (University of Georgia). It is being developed by RFS Pharma.[1] Currently, it is in Phase II clinical studies.
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />External links
Murphy RL, Kivel NM, Zala C, Ochoa C, Tharnish P, Mathew J, Pascual ML, Schinazi RF (2010). "Antiviral activity and tolerability of amdoxovir with zidovudine in a randomized double-blind placebo-controlled study in HIV-1-infected individuals". Antivir Ther. 15 (2): 185–192. doi:10.3851/IMP1514. PMID 20386073.
| 50px | This antiinfective drug article is a stub. You can help ssf by expanding it. |
- ↑ "AIDSmeds.com - Amdoxovir". Retrieved 2008-03-21.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- CS1 maint: Multiple names: authors list
- Nucleoside analog reverse transcriptase inhibitors
- Purines
- Dioxolanes
- Antiinfective agent stubs
- 2Fix
